APPLICATION
ANDA206879
TYPE
ANDA
ORIGINAL APPROVAL
2017-10-06
LATEST ACTION
2023-06-07
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Prescription
Products
NEVIRAPINEPrescription
NEVIRAPINE 400MG · TABLET, EXTENDED RELEASE · ORAL
Approval history
2023-06-07Labeling · Supplement 15 · standardAP
2019-08-14Labeling · Supplement 6 · standardAP
2017-10-06UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.